4th COVID-19 Booster Recommended for those with Chronic Liver Disease

June 21, 2022

The Australian Technical Advisory Group on Immunisation (ATAGI) recommends a fourth COVID-19 vaccine dose for people with a range of immunocompromising conditions including chronic liver diseases such as cirrhosis, autoimmune hepatitis, non-alcoholic fatty liver disease, and alcoholic liver disease.

ATAGI said an extra winter booster should be given four months after the initial booster but should be delayed three months after a confirmed COVID-19 infection has cleared. Any Australian with a chronic, terminal, or severe illness, or those suffering from a significant disability are now eligible for the fourth dose. ATAGI also encourages those over 65 to consider the fourth dose during flu season. This new scheme aims to prevent poor outcomes of COVID-19 for those who are immunocompromised, during the winter months.

ATAGI has advised that the flu vaccine could still be given ahead of the additional booster for patients not yet eligible for a fourth dose.

ATAGI Booster Advice
We are here to answer your queries and support you. Call or chat with us online.
LiverWELL acknowledges the support of the Victorian Government.
We acknowledge and pay respect to the past, present and future Traditional Custodians and Elders of this nation and the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples.

We welcome people from all cultures, nationalities and religions. Being inclusive and providing equitable services is our commitment.

ABN 48 656 812 701